KMX vs VYNE · P/E 19, rev $25.88B vs rev $501.0K
CarMax Inc (KMX) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported KMX revenue for 2026-02-28 was $25.88B. Net income was $247.3M. Revenue was down 1.8% from 2025-02-28 to 2026-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
KMX currently screens at market cap $10.26B and trailing P/E 18.9. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the KMX and VYNE stock pages for the full models.
Not investment advice.